These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36959137)

  • 1. Molecular Pathology and Therapeutic Strategies of Type 2 Diabetes.
    Liao HZ; Liang Y; Wang Y; Liang C
    Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1392-1399. PubMed ID: 36959137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.
    Malavazos AE; Iacobellis G; Dozio E; Basilico S; Di Vincenzo A; Dubini C; Menicanti L; Vianello E; Meregalli C; Ruocco C; Ragni M; Secchi F; Spagnolo P; Castelvecchio S; Morricone L; Buscemi S; Giordano A; Goldberger JJ; Carruba M; Cinti S; Corsi Romanelli MM; Nisoli E
    Eur J Prev Cardiol; 2023 Jun; 30(8):680-693. PubMed ID: 36799940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide.
    Guo XH
    Curr Med Res Opin; 2016; 32(1):61-76. PubMed ID: 26439329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
    Baretić M; Troskot R
    Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity.
    Usui R; Yabe D; Seino Y
    J Diabetes Investig; 2019 Jul; 10(4):902-905. PubMed ID: 30637966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Past and current perspective on new therapeutic targets for Type-II diabetes.
    Patil PD; Mahajan UB; Patil KR; Chaudhari S; Patil CR; Agrawal YO; Ojha S; Goyal SN
    Drug Des Devel Ther; 2017; 11():1567-1583. PubMed ID: 28579755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Co-administration of intranasally delivered insulin and proinsulin C-peptide to rats with the types 1 and 2 diabetes mellitus restores their metabolic parameters.].
    Derkach KV; Bondareva VM; Shpakov AO
    Adv Gerontol; 2017; 30(6):851-858. PubMed ID: 29608829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HYPERGLYCEMIA AND HYPOGLYCEMIA IN PATIENTS WITH DIABETES IN SKILLED NURSING FACILITIES.
    Patell R; Nigmatoulline D; Bena J; Kim DG; Messinger-Rapport B; Lansang MC
    Endocr Pract; 2017 Apr; 23(4):458-465. PubMed ID: 28156156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Diabetes Mellitus in Normal Renal Function, Renal Dysfunction and Renal Transplant Recipients, Focusing on Glucagon-Like Peptide-1 Agonist: A Review Based upon Current Evidence.
    Tsai SF; Chen CH
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Old and Novel Therapeutic Approaches in the Management of Hyperglycemia, an Important Risk Factor for Atherosclerosis.
    Janjusevic M; Fluca AL; Gagno G; Pierri A; Padoan L; Sorrentino A; Beltrami AP; Sinagra G; Aleksova A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical assessment of glucagon-like peptide 1 receptor (GLP-1R) expression in the pancreas of patients with type 2 diabetes.
    Kirk RK; Pyke C; von Herrath MG; Hasselby JP; Pedersen L; Mortensen PG; Knudsen LB; Coppieters K
    Diabetes Obes Metab; 2017 May; 19(5):705-712. PubMed ID: 28094469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro and In Vivo Antidiabetic Potential of Monoterpenoids: An Update.
    Al Kury LT; Abdoh A; Ikbariah K; Sadek B; Mahgoub M
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic therapy before and 1 year after discharge for patients manifesting in-hospital hyperglycemia.
    Waddell M; Flanders SJ; Golas A; Zhang Q; Juneja R
    Postgrad Med; 2009 May; 121(3):61-6. PubMed ID: 19491541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in type 2 diabetes mellitus: combination therapy with a thiazolidinedione.
    Braunstein S
    Clin Ther; 2003 Jul; 25(7):1895-917. PubMed ID: 12946541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To do one and to get more: Part II. Diabetes and metabolic dysfunction-associated fatty liver diseases.
    Lee WL; Wang PH; Yang ST; Liu CH; Chang WH; Lee FK
    J Chin Med Assoc; 2022 Dec; 85(12):1109-1119. PubMed ID: 36279128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal Medicines for Diabetes Management and its Secondary Complications.
    Kumar S; Mittal A; Babu D; Mittal A
    Curr Diabetes Rev; 2021; 17(4):437-456. PubMed ID: 33143632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model.
    Yang SC; Hsu CY; Chou WL; Fang JY; Chuang SY
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Insulin Receptor Antibodies in the Pathology and Therapy of Diabetes Mellitus.
    Ashraf A; Palakkott A; Ayoub MA
    Curr Diabetes Rev; 2021; 17(2):198-206. PubMed ID: 32496987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.